News

The stock's rise snapped a three-day losing streak.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
Kenvue on Thursday forecast that its annual profit would be flat year-over-year as the consumer health firm anticipates a ...
Shares of Kenvue rose in premarket trading Thursday after the maker of Band-Aid, Tylenol, and Listerine reported ...
The Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new ...
Kenvue Inc. (NYSE: KVUE), today announced the appointment of Amit Banati as the Company’s Chief Financial Officer, effective ...
Kenvue beat analysts' expectations for first-quarter profit and revenue on Thursday, as strong demand for its self-care ...
Kenvue Inc. maintained its sales expectations for the year while lowering its profitability target as tariffs raise costs.
(Reuters) -Kenvue beat quarterly profit and revenue estimates on Thursday as better-than-expected demand for cough-and-cold ...
This was the stock's third consecutive day of losses.
Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsSofya Tsinis - Head of Investor RelationsThibaut ...
Discover Kenvue's Q1 2025 earnings insights—strategic growth, tariff mitigation, innovation focus, and supply chain resilience to drive performance this year.